Dr Lucie Abeler-Dorner
Contact information
Lucie Abeler-Dörner
PhD
Scientific Manager, Nuffield Department of Medicine
Having joined Christophe’s team as a scientific manager in November 2017, my current focus is to get the Pangea-2 consortium up and running.
My background is in immunology. After a PhD and a postdoc, I spent five years project-managing the Immunity and Infection Immunophenotyping consortium (3i), an open access consortium analysing over 500 knockout strains with a focus on immunological phenotypes observed in the steady state and under challenge.
My interests include systemic and tissue-specific immune regulation and computational approaches to immunological and virological "big data". I enjoy finding creative solutions for complex problems, juggling a diverse set of tasks, learning new things, getting the best out of every team member and discussing science with expert and non-expert audiences.
Recent publications
Patterns of HIV-1 Viral Load Suppression and Drug Resistance During the Dolutegravir Transition: A Population-based Longitudinal Study.
Journal article
Martin MA. et al, (2026), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 82, e1242 - e1251
Ethical challenges in outbreak trial design: from Ebola to Nipah.
Journal article
Jamrozik E. et al, (2026), Vaccine, 89
Accelerating vaccine trials during an outbreak of Disease-X: the effect of pathogen super-spreading on ring-trial design
Preprint
Hinch R. et al, (2026)
HIV drug resistance during antiretroviral therapy scale-up in Uganda, 2012-19: a population-based, longitudinal study.
Journal article
Martin MA. et al, (2025), The Lancet. Microbe, 6
Large connected components in sexual networks and their role in HIV transmission in Sub-Saharan Africa: A model-based analysis of HPTN 071(PopART) data.
Journal article
Di Lauro F. et al, (2025), Journal of theoretical biology, 613